| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/12/2011 | US20110107820 Use of a steroid profile in ovarian follicular fluid for diagnosis, prognosis and determining strategies for treatment |
| 05/12/2011 | US20110107813 Breath Test Simulator and Method |
| 05/12/2011 | DE102009053225A1 Verfahren zur Bestimmung der totalen Hämoglobinmenge im Körper eines Lebewesens Method for determining the total amount of hemoglobin in the body of a living |
| 05/12/2011 | DE102009052473A1 Device for detecting hydrogen concentration in gas mixture in exhaust pipe of fuel cell system in vehicle, has partial elements running parallel to given flow length, where one of partial elements forms volumes with hydrogen sensor |
| 05/12/2011 | DE102009052134A1 Method for detecting analytes in a sample, comprises permanently fixing a holder that carries sensor molecules in an immobilization area, in a cavity over a transparent cavity base |
| 05/12/2011 | DE102009046521A1 Schutzvorrichtung für ein Kraftfahrzeug Protection device for a motor vehicle |
| 05/12/2011 | DE102009016512B4 Verfahren und Vorrichtung zur Durchführung einer quantitativen ortsaufgelösten Lokal- und Verteilungsanalyse chemischer Elemente und in-situ Charakterisierung der ablatierten Oberflächenregionen A method and apparatus for performing a quantitative and spatially resolved local distribution analysis of chemical elements and in-situ characterization of the ablated surface regions |
| 05/12/2011 | DE102007013736B4 Verfahren zur Detektion von Bakterien in aus Blut abgeleiteten Proben mittels Sauerstoff-Konzentrationsbestimmung A method for detection of bacteria in blood-derived sample by means of oxygen-concentration determination |
| 05/12/2011 | DE102006046079B4 Verfahren und Kit zur Analyse des DNA-Gehalts von Zellen A method and kit for the analysis of the DNA content of cells |
| 05/12/2011 | CA2816437A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | CA2780436A1 Improved methods of enzymatic hydrolysis |
| 05/12/2011 | CA2780153A1 Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders |
| 05/12/2011 | CA2779905A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/12/2011 | CA2779902A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/12/2011 | CA2779846A1 Positively charged species as binding reagents in the separation of protein aggregates from monomers |
| 05/12/2011 | CA2779839A1 T-cell stimulating protein b and methods of use |
| 05/12/2011 | CA2779730A1 Compositions and methods for detecting plectin-1 as a biomarker for cancer |
| 05/12/2011 | CA2779726A1 Ex host maturation of germline stem cells |
| 05/12/2011 | CA2779701A1 Germline stem cell banking system |
| 05/12/2011 | CA2779688A1 Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry |
| 05/12/2011 | CA2779526A1 Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection |
| 05/12/2011 | CA2779515A1 Haemophilus parasuis polypeptides and methods of use |
| 05/12/2011 | CA2779281A1 Catenae: serosal cancer stem cells |
| 05/12/2011 | CA2779223A1 Molecular profiling for personalized medicine |
| 05/12/2011 | CA2778810A1 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis |
| 05/12/2011 | CA2778552A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | CA2778454A1 Assays for the detection of anti-tnf drugs and autoantibodies |
| 05/12/2011 | CA2778254A1 Secretory protein biomarkers for high efficiency protein expression |
| 05/12/2011 | CA2778234A1 Methods and compositions for modulating tau levels |
| 05/12/2011 | CA2777169A1 Diagnostic methods for determining prognosis of non-small cell lung cancer |
| 05/11/2011 | EP2320343A2 System and process for validating, aligning and reordering one or more genetic sequence maps using at least one ordered restriction map |
| 05/11/2011 | EP2320237A1 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
| 05/11/2011 | EP2320236A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 05/11/2011 | EP2320235A1 Marker for prostate cancer diagnosis |
| 05/11/2011 | EP2320234A1 Marker combination for prostate cancer diagnosis |
| 05/11/2011 | EP2320233A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 05/11/2011 | EP2320232A1 Liquid specimen analysis device |
| 05/11/2011 | EP2320231A2 Assays involving sam-modified colloids and non-colloidal structures |
| 05/11/2011 | EP2320230A1 Reagent for detecting abnormal cell in cervix of uterus, and method for detecting abnormal cell in cervix of uterus by using same |
| 05/11/2011 | EP2320229A2 System and process for validating, aligning and reordering one or more genetic sequence maps using at least one ordered restriction map |
| 05/11/2011 | EP2320228A1 Determination of white blood cell differential and reticulocyte counts |
| 05/11/2011 | EP2320227A1 Dissolution apparatus comprising beads and process |
| 05/11/2011 | EP2320214A2 Multi-Channel Source Assembly for Downhole Spectroscopy |
| 05/11/2011 | EP2320213A2 Multi-Channel Detector Assembly for Downhole Spectroscopy |
| 05/11/2011 | EP2320210A2 Protective device for a motor vehicle |
| 05/11/2011 | EP2320209A1 Tissue piece forming device and tissue piece forming method |
| 05/11/2011 | EP2320208A1 Blood collection container |
| 05/11/2011 | EP2320027A1 Movable filter assembly for downhole spectroscopy |
| 05/11/2011 | EP2320026A1 A method and apparatus for a downhole micro-sampler |
| 05/11/2011 | EP2319938A1 Method for detecting chromosome deficiencies for congenital abnormality |
| 05/11/2011 | EP2319937A1 Blood component measurement method utilizing hemolyzed whole blood, and kit for the method |
| 05/11/2011 | EP2319936A2 Yeast screens for agents affecting protein folding |
| 05/11/2011 | EP2319931A1 Extracellular matrix-binding proteins from staphylococcus aureus |
| 05/11/2011 | EP2319924A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 05/11/2011 | EP2319919A1 Nitrilases |
| 05/11/2011 | EP2319917A2 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/11/2011 | EP2319916A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319869A1 ANTIBODY AGAINST OXIDIZED LDL/ß²GPI COMPLEX AND USE OF THE SAME |
| 05/11/2011 | EP2319868A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/11/2011 | EP2319866A2 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 05/11/2011 | EP2319861A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 05/11/2011 | EP2319617A1 Arrays of microparticles and methods of preparation thereof |
| 05/11/2011 | EP2319536A1 Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319526A1 Tdf-related compounds and analogs thereof |
| 05/11/2011 | EP2319524A1 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 05/11/2011 | EP2319318A2 Methods of identifying compounds that target TRNA splicing endonuclease and uses of said compounds as anti-proliferative agents |
| 05/11/2011 | EP2318844A1 Multimarker panel for diagnosing, monitoring and selecting the therapy for patients with heart failure |
| 05/11/2011 | EP2318843A1 Methods and kits for predicting the onset of labour |
| 05/11/2011 | EP2318842A1 Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways |
| 05/11/2011 | EP2318841A1 Anln protein as an endocrine treatment predictive factor |
| 05/11/2011 | EP2318840A1 Primitive vascular progenitor cells and uses thereof |
| 05/11/2011 | EP2318839A1 Hydrolysis-resistant polyacrylamide gels |
| 05/11/2011 | EP2318838A1 High capacity solid phase |
| 05/11/2011 | EP2318837A2 Enhanced immunoassay sensor |
| 05/11/2011 | EP2318836A1 Pan-kinase activation and evaluation of signaling pathways |
| 05/11/2011 | EP2318835A2 Nanostructured optical fiber illumination systems and methods for biological applications |
| 05/11/2011 | EP2318834A2 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics |
| 05/11/2011 | EP2318833A1 Separation of blood cells from a blood sample |
| 05/11/2011 | EP2318831A1 Handheld apparatus to determine the viability of a biological tissue |
| 05/11/2011 | EP2318830A1 Ex vivo therapeutic screening of living bone marrow cells for multiple myeloma |
| 05/11/2011 | EP2318823A1 Methods and devices for assessment of mitochondrial function |
| 05/11/2011 | EP2318821A2 Method for precisely determining the fluorescence in a layer system, such as the eye |
| 05/11/2011 | EP2318553A2 Markers for assessing the susceptibility of cancer to igf-1r treatment |
| 05/11/2011 | EP2318552A2 Methods for stratifying and annotating cancer drug treatment options |
| 05/11/2011 | EP2318551A1 System and methods for measuring biomarker profiles |
| 05/11/2011 | EP2318549A2 Detecting nucleic acid |
| 05/11/2011 | EP2318546A2 Marker sequences for inflammatory prostate diseases, prostate carcinoma and their use |
| 05/11/2011 | EP2318540A1 Enzymatical modif ication of cell glycosylation using serum albumin and divalent cations |
| 05/11/2011 | EP2318507A1 Method, kit and system for culturable cell count |
| 05/11/2011 | EP2318304A1 Switches for microfluidic systems |
| 05/11/2011 | EP2318051A2 In vitro diagnostic markers comprising carbon nanoparticles and kits |
| 05/11/2011 | EP2318028A2 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 05/11/2011 | EP2318021A1 Protocols for treating and preventing obesity and complications arising therefrom |
| 05/11/2011 | EP2317911A2 Transcutaneous organ function measurement |
| 05/11/2011 | EP2317909A1 Medical system comprising compact barcode readers for consumable items |
| 05/11/2011 | EP2234724B1 Apparatus and method for detecting dna damage |
| 05/11/2011 | EP2201361B1 Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patients |
| 05/11/2011 | EP2013605B1 Device for determining the stiffness of flexible materials |